S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:CLPT

ClearPoint Neuro Stock Forecast, Price & News

$17.34
-2.73 (-13.60 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.01
Now: $17.34
$19.87
50-Day Range
$15.76
MA: $23.51
$29.00
52-Week Range
$2.86
Now: $17.34
$31.29
Volume2.35 million shs
Average Volume469,657 shs
Market Capitalization$337.52 million
P/E RatioN/A
Dividend YieldN/A
Beta1.15
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for insertion of catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to allow catheter-based minimally invasive procedures in the heart to be performed in an MRI suite. The company has a license agreements with The Johns Hopkins University; development agreement with Mayo Clinic to design and develop MRI-guided therapies for stroke; and a collaborative license and co-development agreement with Clinical Laserthermia Systems AB. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was founded in 1998 and is headquartered in Irvine, California.
ClearPoint Neuro logo

Headlines

SLV Jan 2021 26.000 call
January 2, 2021 |  uk.finance.yahoo.com
SLV Feb 2021 15.500 call
December 23, 2020 |  uk.finance.yahoo.com
ClearPoint Neuro EPS beats by $0.06, beats on revenue
November 10, 2020 |  seekingalpha.com
Recap: ClearPoint Neuro Q3 Earnings
November 10, 2020 |  benzinga.com
ClearPoint Neuro, Inc. Common Stock (CLPT)
October 28, 2020 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CLPT
CUSIPN/A
CIKN/A
Phone949 900 6833
Employees49
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.22 million
Book Value$0.30 per share

Profitability

Net Income$-5,540,000.00

Miscellaneous

Market Cap$337.52 million
Next Earnings Date5/11/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.40 out of 5 stars

Medical Sector

624th out of 1,972 stocks

Surgical & Medical Instruments Industry

65th out of 169 stocks

Analyst Opinion: 3.5Community Rank: 3.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$17.34
-2.73 (-13.60 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLPT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ClearPoint Neuro (NASDAQ:CLPT) Frequently Asked Questions

Is ClearPoint Neuro a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ClearPoint Neuro in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ClearPoint Neuro stock.
View analyst ratings for ClearPoint Neuro
or view top-rated stocks.

What stocks does MarketBeat like better than ClearPoint Neuro?

Wall Street analysts have given ClearPoint Neuro a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ClearPoint Neuro wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting ClearPoint Neuro?

ClearPoint Neuro saw a decrease in short interest in February. As of February 12th, there was short interest totaling 198,100 shares, a decrease of 45.1% from the January 28th total of 360,800 shares. Based on an average daily volume of 318,200 shares, the days-to-cover ratio is currently 0.6 days. Currently, 1.4% of the company's stock are sold short.
View ClearPoint Neuro's Short Interest
.

When is ClearPoint Neuro's next earnings date?

ClearPoint Neuro is scheduled to release its next quarterly earnings announcement on Tuesday, May 11th 2021.
View our earnings forecast for ClearPoint Neuro
.

How were ClearPoint Neuro's earnings last quarter?

ClearPoint Neuro, Inc. (NASDAQ:CLPT) issued its quarterly earnings data on Wednesday, March, 3rd. The company reported ($0.09) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.13) by $0.04. ClearPoint Neuro had a negative net margin of 55.55% and a negative trailing twelve-month return on equity of 309.91%.
View ClearPoint Neuro's earnings history
.

What guidance has ClearPoint Neuro issued on next quarter's earnings?

ClearPoint Neuro updated its fourth quarter 2020 After-Hours earnings guidance on Tuesday, January, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.7-3.7 million, compared to the consensus revenue estimate of $3.29 million.

What price target have analysts set for CLPT?

2 brokerages have issued 12-month target prices for ClearPoint Neuro's shares. Their forecasts range from $15.00 to $38.00. On average, they expect ClearPoint Neuro's stock price to reach $26.50 in the next year. This suggests a possible upside of 52.8% from the stock's current price.
View analysts' price targets for ClearPoint Neuro
or view top-rated stocks among Wall Street analysts.

Who are ClearPoint Neuro's key executives?

ClearPoint Neuro's management team includes the following people:
  • Mr. Joseph Michael Burnett, Pres, CEO & Director (Age 44, Pay $609.74k)
  • Mr. Peter G. Piferi, Chief Operating Officer (Age 62, Pay $376.85k)
  • Mr. Danilo D'Alessandro, Chief Financial Officer
  • Ms. Jacqueline Keller, VP of Marketing
  • Dr. Paul A. Bottomley, Advisor (Age 68)

Who are some of ClearPoint Neuro's key competitors?

What is ClearPoint Neuro's stock symbol?

ClearPoint Neuro trades on the NASDAQ under the ticker symbol "CLPT."

Who are ClearPoint Neuro's major shareholders?

ClearPoint Neuro's stock is owned by a variety of retail and institutional investors. Top institutional investors include Parian Global Management LP (2.71%), CM Management LLC (1.23%), Parsons Capital Management Inc. RI (0.81%), ExodusPoint Capital Management LP (0.31%), Renaissance Technologies LLC (0.31%) and BlackRock Inc. (0.28%).

Which major investors are selling ClearPoint Neuro stock?

CLPT stock was sold by a variety of institutional investors in the last quarter, including Merriman Wealth Management LLC, Parsons Capital Management Inc. RI, Brown Advisory Inc., and BlackRock Inc..

Which major investors are buying ClearPoint Neuro stock?

CLPT stock was acquired by a variety of institutional investors in the last quarter, including Parian Global Management LP, CM Management LLC, ExodusPoint Capital Management LP, JPMorgan Chase & Co., Westwood Management Corp IL, Lucas Capital Management, Renaissance Technologies LLC, and One68 Global Capital LLC.

How do I buy shares of ClearPoint Neuro?

Shares of CLPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ClearPoint Neuro's stock price today?

One share of CLPT stock can currently be purchased for approximately $17.34.

How much money does ClearPoint Neuro make?

ClearPoint Neuro has a market capitalization of $337.52 million and generates $11.22 million in revenue each year. The company earns $-5,540,000.00 in net income (profit) each year or ($0.42) on an earnings per share basis.

How many employees does ClearPoint Neuro have?

ClearPoint Neuro employs 49 workers across the globe.

What is ClearPoint Neuro's official website?

The official website for ClearPoint Neuro is www.clearpointneuro.com.

Where are ClearPoint Neuro's headquarters?

ClearPoint Neuro is headquartered at 5 MUSICK, IRVINE CA, 92618.

How can I contact ClearPoint Neuro?

ClearPoint Neuro's mailing address is 5 MUSICK, IRVINE CA, 92618. The company can be reached via phone at 949 900 6833 or via email at [email protected]


This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.